USANA Health Sciences Inc (USNA) income statement
USNANYSEMedicinal Chemicals & Botanical ProductsFiscal year ends January 3
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jul 4, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3058% below fair value
$13.22−0.35 (-2.58%)
Close on Nov 18, 2026Market cap $244.26MP/E –Yield –
USANA Health Sciences Inc income statement
Ratios
Latest available, balances at Jul 4, 2026
Profitability, TTM
- Gross margin
- 77.4%
- Operating margin
- -0.1%
- Net margin
- -2.4%
- Return on equity, FY2025
- 2.0%
Financial strength
- Current ratio
- 2.66
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 159.5%
Valuation
- P/E ratio
- –
- Price to sales
- 0.27
- Price to book
- 0.46
- Dividend yield
- –
See a number that looks wrong?